Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 9/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.49 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8189163 | 0.85 | NISCH (0.61) | NISCHMAOBNPC1RAB9ACYP19A1 | |
| SCHEMBL14535010 | 0.78 | PRMT1 (0.70) | NISCH | |
| SCHEMBL8229714 | 0.75 | PRMT1 (0.71) | NISCH | |
| SCHEMBL8238119 | 0.74 | PRMT1 (0.69) | NISCH | |
| SCHEMBL29631691 | 0.73 | RAB9A (0.74) | KDM4ECYP1A2ALDH1A1HPGDHSD17B10 | |
| SCHEMBL374022 | 0.73 | RAB9A (0.74) | KDM4ECYP1A2ALDH1A1HPGDHSD17B10 | |
| SCHEMBL362453 | 0.73 | PRMT1 (0.68) | NISCH | |
| Hydrochloric Acid SCHEMBL3383477 | 0.72 | PRMT1 (0.66) | NISCH | |
| SCHEMBL8952772 | 0.70 | KDM4E (0.58) | NISCHKDM4ECYP1A2ALDH1A1CYP2D6 | |
| SCHEMBL6587783 | 0.70 | ADRA2A (0.50) | NISCHCYP1A2CYP2D6ADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8053457-B2 | 3-imidazolyl-indoles for the treatment of proliferative diseases | NOVARTIS AG (CH) | 2011-11-08 | — | — | US | disclosed |
| US-20100125064-A1 | 3-Imidazolyl-Indoles for the Treatment of Proliferative Diseases | NOVARTIS AG (CH) | 2010-05-20 | — | — | US | disclosed |
| EP-2142535-A2 | 3-IMIDAZOLYL-INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | Novartis Ag (CH) | 2010-01-13 | — | — | EP | disclosed |
| WO-2008119741-A2 | 3-IMIDAZOLYL-INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | NOVARTIS AG (CH) | 2008-10-09 | — | — | WO | disclosed |
| US-20040009976-A1 | Hypoglycemic imidazoline compounds | TAKEUCHI KUMIKO (US) | 2004-01-15 | — | — | US | disclosed |
| US-6410562-B1 | ANTIDIABETIC AGENTS | ELI LILLY AND COMPANY | 2002-06-25 | — | — | US | disclosed |
| US-5523279-A | COMPOSITION FOR CONTROLLING MONOCOTYLEDENOUS AND DICOTYLEDENOUS PLANT SPECIES | AMERICAN CYANAMID COMPANY (US) | 1996-06-04 | — | — | US | disclosed |
| US-5523279-A | COMPOSITION FOR CONTROLLING MONOCOTYLEDENOUS AND DICOTYLEDENOUS PLANT SPECIES | AMERICAN CYANAMID COMPANY (US) | 1996-06-04 | — | — | US | disclosed |
| US-5516751-A | NONPHYTOTOXIC; SUGAR BEETS, SOYBEANS | AMERICAN CYANAMID COMPANY (US) | 1996-05-14 | — | — | US | disclosed |
| US-5516751-A | NONPHYTOTOXIC; SUGAR BEETS, SOYBEANS | AMERICAN CYANAMID COMPANY (US) | 1996-05-14 | — | — | US | disclosed |
| EP-0474991-B1 | Herbicidal 2-(2-imidazolin -2-yl)-benzazoles | AMERICAN CYANAMID CO (US) | 1995-10-18 | — | — | EP | disclosed |
| US-5385919-A | Antidiabetic agents | RECKITT & COLMAN PRODUCTS LIMITED (GB) | 1995-01-31 | — | — | US | disclosed |
| US-5108485-A | Controlling monocotyledonous and dicotyledonous plants | AMERICAN CYANAMID COMPANY (US) | 1992-04-28 | — | — | US | disclosed |
| EP-0474991-A1 | Herbicidal 2-(2-imidazolin -2-yl)-benzazoles | AMERICAN CYANAMID COMPANY (US) | 1992-03-18 | — | — | EP | disclosed |
| US-5017584-A | Antidepressant 2-(4,5-dihydro-1H-imidazolyl)-dihydro-1H-indoles, -1,2,3,4-tetrahydroquinolines and -1H-indoles, and methods of use thereas | STERLING DRUG INC. (US) | 1991-05-21 | — | — | US | disclosed |
| US-5017584-A | Antidepressant 2-(4,5-dihydro-1H-imidazolyl)-dihydro-1H-indoles, -1,2,3,4-tetrahydroquinolines and -1H-indoles, and methods of use thereas | STERLING DRUG INC. (US) | 1991-05-21 | — | — | US | disclosed |
| EP-0003901-B1 | 3-(IMIDAZOL-1-YLALKYL)INDOLES AS SELECTIVE INHIBITORS OF THROMBOXANE SYNTHETASE,PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR PREPARING THEM | Pfizer Limited (GB) | 1981-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040009976-A1 | Hypoglycemic imidazoline compounds | GPR119, IAPP, GLP1R | NISCH 277/4885KDM4E 2605/4885CYP1A2 1285/4885 |
| US-20100125064-A1 | 3-Imidazolyl-Indoles for the Treatment of Proliferative Diseases | MDM4, TP53, MDM2 | NISCH 2458/4885KDM4E 920/4885CYP1A2 1527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.